Myocardial Infarction

Results of the TRANSLATE-POPS trial presented

According to a new study of heart attack patients treated with percutaneous coronary intervention (PCI), free access to platelet function testing had only a modest impact on anti-clotting drug selection and dosing. Findings ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the HYBRID trial presented

A hybrid approach to treating coronary artery disease that involves a "hybrid procedure" combining a minimally invasive bypass surgery with percutaneous coronary intervention (PCI) was found to be feasible and safe in a clinical ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the FREEDOM sub study reported

According to a recent study of diabetic patients who underwent revascularization for multi-vessel coronary artery disease (CAD), patients treated with insulin experienced more major adverse cardiovascular events after revascularization ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of DUTCH PEERS (TWENTE II) trial reported

Results of the DUTCH PEERS (TWENTE II) clinical trial demonstrate comparable safety and efficacy of two third-generation permanent polymer-based drug-eluting stents with low rates of adverse clinical events and establish ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the ARCTIC-INTERRUPTION trial presented

According to a new study, patients that do not experience a major cardiac event in the first year after receiving drug-eluting stent (DES) may not need to receive prolonged dual antiplatelet therapy (DAPT). Results from the ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the OPTIMIZE trial presented

A new study demonstrates that some patients may not need to receive prolonged anti-clotting therapy after drug-eluting stent (DES) implantation with the Endeavor zotarolimus-eluting stent, and that shortening the duration ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the CHILL-MI trial presented

A clinical trial shows that rapidly cooling patients who have suffered ST-elevation myocardial infarction (STEMI, the most serious form of a heart attack) prior to restoring blood flow is safe and feasible. The findings of ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the SMART-CASE trial presented

A new study shows that a conservative approach to revascularization for patients with intermediate coronary lesions determined by angiographic diameter stenosis is safe and non-inferior to an aggressive approach. Findings ...

Oct 30, 2013
popularity not rated yet | comments 0

Results of the TRYTON trial presented

A clinical trial designed to measure the effectiveness of using a dedicated side branch-covering bare metal stent in true bifurcation coronary lesions found that that the strategy was safe, but the results did not establish ...

Oct 30, 2013
popularity not rated yet | comments 0

Results of the SORT-OUT VI trial presented

A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with biodegradable polymers were associated with low major adverse coronary events, demonstrating the non-inferiority of the biocompatible ...

Oct 30, 2013
popularity not rated yet | comments 0

Latest Spotlight News

New malaria vaccine candidates identified

Researchers have discovered new vaccine targets that could help in the battle against malaria. Taking a new, large-scale approach to this search, researchers tested a library of proteins from the Plasmodium fa ...

Brainwaves can predict audience reaction

Media and marketing experts have long sought a reliable method of forecasting responses from the general population to future products and messages. According to a study conducted at The City College of New ...